The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Aicuris Anti Infective Cures competitive analysis

Loading summary...

Latest oppositions filed by Aicuris Anti Infective Cures

Explore patent oppositions filed by Aicuris Anti Infective Cures against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3440063
Aminothiazole Derivatives Useful As Antiviral AgentsINNOVATIVE MOLECULESMay 5, 2021

Latest patents of Aicuris Anti Infective Cures opposed by its competitors

Explore Aicuris Anti Infective Cures's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3544976
Feb 17, 2021N-[5-(Aminosulfonyl)-4-Methyl-1,3-Thiazol-2-Yl]-N-Methyl-2-[4-(2-Pyridinyl)-Phenyl]-Acetamide Free Base Hemihydrate, Methods Of Manufacture And Uses Thereof1

Latest PTAB cases involving Aicuris Anti Infective Cures

Discover the latest PTAB cases involving Aicuris Anti Infective Cures, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Aicuris Anti Infective Cures with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
AICURIS ANTI INFECTIVE CURES11 - -
INNOVATIVE MOLECULES11 - -